Cartesian Therapeutics In...

NASDAQ: RNAC · Real-Time Price · USD
9.18
0.04 (0.38%)
At close: May 23, 2025, 3:59 PM
9.16
-0.22%
After-hours: May 23, 2025, 04:04 PM EDT

Cartesian Therapeutics Revenue

Cartesian Therapeutics reported an annual revenue of $38.91M, reflecting a 49.64% growth. For the quarter ending March 31, 2025, Cartesian Therapeutics generated $1.1M in revenue.
Revenue (ttm)
$38.91M
Revenue Growth
49.64%
Price / Sales Ratio
7.95
Revenue / Employee
$589.59K
Employees
66
Market Cap
238.26M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.